# FemtoMarch

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/femtomarch

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: http://8.134.188.174
- Total disclosed funding: $15M
- Latest round: Angel (Apr 20, 2026)
- Investors on record: 4

## About

Based in Shenzhen, China, and founded in 2022, Shenzhen FemtoMarch Medical Technology Co., Ltd., dba FemtoMarch, focuses on the clinical translation of femtosecond lasers in ophthalmic surgery. The company was established by femtosecond laser scientists from the Chinese Academy of Sciences and senior medical industry experts. In June 2025, the company's prototype of ophthalmic femtosecond laser treatment system passed the national type test.

In March 2026, Femto March raised a series B funding led by Zero2IPO Fund of Funds.

FemtoMarch's main products include ophthalmic femtosecond laser treatment system used in ophthalmic surgery.

The company’s revenue is generated by providing ophthalmic femtosecond laser treatment systems.

The series B round of financing will be mainly used for expanding Femto March's R&D team, product iteration, and market promotion, further enhancing its leading position in the field of ophthalmic medical devices.

## Funding rounds

- Angel, Apr 20, 2026, $15M — Zero2IPO Ventures, Zero2IPO, YuanBio Venture
- Series B, Mar 19, 2026 — Zero2IPO Fund of Funds

## Investors

- Zero2IPO Fund of Funds (https://capitalatlas.ai/funds/zero2ipo-fund-of-funds) — Series B
- Zero2IPO Ventures (https://capitalatlas.ai/funds/zero2ipo-ventures) — Angel
- Zero2IPO — Angel
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Angel